Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

CSP403 - Trial of varicella zoster vaccine for the prevention of herpes zoster and its complications

Next Previous
Trial Profile

CSP403 - Trial of varicella zoster vaccine for the prevention of herpes zoster and its complications

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 06 May 2022

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Most Recent Events

  • 12 Apr 2016 Results (post hoc pooled analysis of this and other study, n = 28785) assessing severe injection-site and systemic AEs presented at the 26th European Congress of Clinical Microbiology and Infectious Diseases.
  • 25 Oct 2008 Results published as an abstract in the proceedings of the 48th Interscience Conference on Antimicrobial Agents and Chemotherapy and 46th Annual Meeting of the Infectious Diseases Society of America.
  • 01 Mar 2008 Results reported in the Journal of Infectious Disease.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top